Lemonade (LMND) has drawn fresh investor attention after favorable commentary on a popular finance show, coupled with its recent addition to the NASDAQ Internet Index, put the AI focused insurer back in the spotlight.
See our latest analysis for Lemonade.
The recent TV spotlight and NASDAQ Internet Index inclusion have arrived after a mixed stretch, with a 1 month share price return of 17.32% contrasting with a 20.09% share price decline year to date. At the same time, the 1 year total shareholder return of 86.94% and 3 year total shareholder return above 3x suggest sentiment has shifted meaningfully over a longer horizon.
If Lemonade’s renewed attention has you thinking about where AI could reshape finance next, it might be a good moment to scan 34 AI small caps.
After a sharp 1 year total return of 86.94% and a 3 year gain above 3x, yet a 20.09% share price decline year to date, investors may now be asking whether Lemonade is undervalued or already pricing in the next leg of growth.
Lemonade’s last close at $60.70 sits below a narrative fair value estimate of $77.14, prompting fresh debate about how much optimism is already in the price.
Lemonade reported in-force premiums of $889 million, up 24% year over year and higher by nearly 50% since mid-2022. The company now has 2.31 million customers, up 17% from year-ago levels, and gross profit climbed 71%.
Want to see what kind of revenue trajectory and profit margins are baked into that fair value, according to VincentE? The core assumptions are anything but conservative.
Result: Fair Value of $77.14 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the narrative could be challenged if loss ratios worsen again or if the business remains tied to a net loss of US$165.5 million.
Find out about the key risks to this Lemonade narrative.
The user narrative points to a fair value of $77.14 and calls Lemonade undervalued, but the market is already attaching a rich P/S ratio of 6.3x. That compares with 1.8x for peers, 1x for the broader US insurance group, and a fair ratio of 1.4x.
Put simply, the current price asks you to accept a valuation that is more than 4x the fair ratio and several times industry norms. This raises the question of how much execution risk you are willing to take on at today’s levels.
See what the numbers say about this price — find out in our valuation breakdown.
With sentiment clearly split between high hopes and real concerns, it makes sense to move fast and study the data for yourself. To weigh both sides clearly, start by checking the 2 key rewards and 1 important warning sign.
If Lemonade has caught your eye, do not stop there. Broaden your opportunity set with focused stock ideas that match how you like to invest.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com